2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
1Liang X,Bi S,Yang W,et al.Epidemiological serosurvey of B in China-declining HBV Prevalence due to hepatitis B vaccination[J].Vaccine,2009,27(47):6550-6557.
2Elefsiniotis IS,Tsoumakas K,Papadakis M,et al.Importance of maternal and cord blood viremia in pregnant women with chronic hepatitis B virus infection[J].Eur J Intern Med,2011,22(2):182-186.
3Bridges E.Telbivudine preclinical safety studies suggest minimal risk of chronic toxicity,reproductive toxicity or carcinogenicity toxicity[J].Hospital,2006,44:5147.
4Han GR,Cao MK,Zhao W,et al.A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection[J].J Herpetology,2011,55(6):1215-1221.
